Cargando…
An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs and tissues. Mesenchymal stem cells (MSCs) are considered a good source for autoimmune disease and hematological disease therapy. This review will summarize the efficacy, safety, and mechanisms of MSC therapy fo...
Autores principales: | Yang, Qian, Liu, Yiping, Chen, Guangyong, Zhang, Wancong, Tang, Shijie, Zhou, Tianbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382560/ https://www.ncbi.nlm.nih.gov/pubmed/34434237 http://dx.doi.org/10.1155/2021/2168595 |
Ejemplares similares
-
Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
por: Zhou, Tianbiao, et al.
Publicado: (2020) -
An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease
por: Lin, Yongda, et al.
Publicado: (2022) -
Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis
por: Liao, Chunling, et al.
Publicado: (2022) -
Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019) -
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)